Advertisement
Screener

vTv Therapeutics Inc. (VTVT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.0 / 5 stars · 28/71 Roast Me

vTv Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

vTv Therapeutics Inc. (VTVT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-10

  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-03-31 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2017-03-31 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-03-31 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-12-310.00%
10-K · filed 2026-03-10
2024-12-310.00%
10-K · filed 2026-03-10
2023-12-310.00%
10-K · filed 2026-03-10
2022-12-310.00%
10-K · filed 2025-03-20
2021-12-310.00%
10-K · filed 2024-03-13
2021-09-300.00%
10-Q · filed 2021-11-09
2020-12-310.00%
10-K · filed 2023-03-06
2020-09-300.00%
10-Q · filed 2021-11-09
2020-06-300.00%
10-Q · filed 2020-08-03
2019-12-310.00%
10-K · filed 2022-03-29
2019-09-300.00%
10-Q · filed 2020-11-05
2019-06-300.00%
10-Q · filed 2020-08-03
2019-03-310.00%
10-Q · filed 2020-05-07
2018-12-310.00%
10-K · filed 2021-02-24
2018-09-300.00%
10-Q · filed 2019-10-30
2018-06-300.00%
10-Q · filed 2019-07-31
2018-03-310.00%
10-Q · filed 2019-05-01
2017-12-310.00%
10-K · filed 2020-02-21
2017-09-300.00%
10-Q · filed 2018-11-08
2017-06-300.00%
10-Q · filed 2018-08-03
2017-03-310.00%
10-Q · filed 2018-05-15
2016-12-310.00%
10-K · filed 2019-02-26
2016-09-300.00%
10-Q · filed 2017-11-01
2016-06-300.00%
10-Q · filed 2017-08-02
2016-03-310.00%
10-Q · filed 2017-05-03
2015-12-310.00%
10-K · filed 2018-02-27
2015-09-300.00%
10-Q · filed 2015-11-13
0.00%
10-Q · filed 2015-11-13